Levi & Korsinsky announces it has commenced an investigation of Spero Therapeutics Inc. (NASDAQ: SPRO) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.
Required Field
Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.
The submission of this form does not create an attorney-client relationship.